Mariyamma Varghese Presti
CIK: 0002131226
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
OPRX
OptimizeRx Corp
Director
Discretionary Trading P&L
Holdings
About Presti Mariyamma Varghese
Presti Mariyamma Varghese (SEC CIK 0002131226) files insider reports with the SEC as Director of OptimizeRx Corp (OPRX).
Signal8 holds 3 ownership filings by Presti Mariyamma Varghese (1 Form 3, 2 Form 4), filed between Apr 22, 2026 and Jun 10, 2026. Those filings report 2 transactions, from May 1, 2026 to Jun 9, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Presti Mariyamma Varghese's filings is in WALTHAM, MA.
Recent filings by Presti Mariyamma Varghese
Other insiders filing for OptimizeRx Corp (OPRX)
- D'Silva Andrew J., Chief Business Officer
- Silvestro Stephen L, Chief Executive Officer
- Merrell Brendan W., CHIEF OPERATING OFFICER
- Odence-Ford Marion, Chief Legal & Admin Officer
- Stelmakh Edward, Chief Finance & Strat Officer
- KLEMA CATHY, Director